Press Room

Press release

Duchesnay USA Pledges Continued Support of the Mobile Mom Squad through Donations of its Mteryti® and Mteryti® folic 5 Prenatal Supplements

Read more >
Press release

Duchesnay Inc. Receives Approval of Supplemental New Drug Application (sNDA) to Add Moderate to Severe Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause, to the Indication of Ospemifene

Read more >
Press release

Duchesnay USA Applauds Expanded Coverage for Treatments for Dyspareunia due to Menopause under Medicare Part D

Read more >
Press release

Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Ospemifene to U.S. FDA

Read more >
Press release

Duchesnay USA Continues the Morning Sickness Conversation with Actress, Mom and Singer Jana Kramer and Beverly Hills Ob/Gyn Dr. Jay Goldberg

Read more >
Press release

Duchesnay Inc. to Present a Poster on Adherence, Persistence and Healthcare Costs Associated with Ospemifene at 2018 Annual Meeting of the North American Menopause Society (NAMS)

Read more >